ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,985.38
0.02%
US Tech 100
20,506.00
-0.05%
Dow Jones
43,958.19
0.11%
Brent Oil
71.795
0.24%
Bitcoin
89,189.83
1.43%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. USA
  5. AMEX

  6. Davis Select US Equity (DUSA) Quote

Davis Select US Equity

Davis Select US Equity (DUSA)

AMEX
44.09
0.08
(0.18%)
At close: November 13 4:00PM
Delayed by 15 minutes
44.09
0.00
( 0.00% )
After Hours: 4:21PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
44.09
Bid
-
Ask
-
Volume
56,410
43.99 Day's Range 44.37
32.2951 52 Week Range 44.40
Previous Close
44.01
Open
44.12
Last Trade
128
@
44.09
Last Trade Time
16:10:01
Average Volume (3m)
20,449
Financial Volume
$ 2,491,285
VWAP
44.1639

DUSA Latest News

More News

DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2009 Financial Results and Corporate Highlights Conference Ca

WILMINGTON, Mass., Feb. 26 /PRNewswire/ -- DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) announces that its 2009 corporate highlights and year end financial results press release will be issued...

February 26 2010
PR Newswire (US)

DUSA Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference

WILMINGTON, Mass., Feb. 2 PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (NASDAQ:DUSA), a specialty pharmaceutical company focused primarily on the development and marketing of its...

February 02 2010
PR Newswire (US)

DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and...

November 06 2009
PR Newswire (US)

DUSA Pharmaceuticals Reports Third Quarter 2009 Corporate Highlights and Financial Results

Q3 Domestic PDT revenues up 32% year over year; Q3 Non-GAAP loss improves 86% year over year to ($0.2) million WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.®...

November 06 2009
PR Newswire (US)

DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units

WILMINGTON, Mass., Oct. 28 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a specialty pharmaceutical company focused on dermatology, announced today that global sales...

October 28 2009
PR Newswire (US)

DUSA Pharmaceuticals Named to Deloitte's 2009 Technology Fast 500 List of Fastest Growing Companies in North America

Second Consecutive Year DUSA Has Been Recognized WILMINGTON, Mass., Oct. 21 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(R) (NASDAQ:DUSA), a specialty pharmaceutical company focused on...

October 21 2009
PR Newswire (US)

DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

WILMINGTON, Mass., Sept. 2 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA), a dermatology company that is developing and marketing Levulan Photodynamic Therapy (PDT) and...

September 02 2009
PR Newswire (US)

DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results

Q2 Domestic PDT revenues up 24% year over year; Kerastick margins reach a record high of 85% WILMINGTON, Mass., Aug. 11 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA), a...

August 11 2009
PR Newswire (US)

DUSA Pharmaceuticals, Inc.(R) Announces Second Quarter Financial Results and Corporate Highlights Conference Call

WILMINGTON, Mass., Aug. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (Nasdaq GM: DUSA) announces that its corporate highlights and second quarter financial results press release will...

August 06 2009
PR Newswire (US)

Amex to Trade Options on Nine Securities

Amex to Trade Options on Nine Securities NEW YORK, March 8 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Tuesday, March 9, 2004, on the underlying...

March 08 2004
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.611.4029438822443.4844.443.4685342744.12148357SP
41.984.7019710282642.1144.441.312555843.0979795SP
123.448.4624846248540.6544.438.662044941.88684595SP
263.899.6766169154240.244.437.52400240.7852973SP
5211.7636.374884008732.3344.432.29512612138.87642788SP
1568.1222.574367528535.9744.424.672525032.97125201SP
26011.3734.749388753132.7244.424.672307533.18019973SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JSPRWJasper Therapeutics Inc
$ 0.30
(61.90%)
100
WKSPWorksport Ltd
$ 1.1899
(36.77%)
4.82M
VEROVenus Concept Inc
$ 0.3999
(19.34%)
2.02k
OXBROxbridge Re Holdings Ltd
$ 2.9799
(15.63%)
100
DLODLocal Ltd
$ 10.44
(15.42%)
197.15k
OPRXOptimizeRx Corporation
$ 5.01
(-18.80%)
18.07k
DBGIDigital Brands Group Inc
$ 0.1471
(-18.48%)
5.96M
ICADIcad Inc
$ 1.92
(-17.77%)
36.77k
QMCOQuantum Corporation
$ 4.0002
(-15.25%)
6.98k
ZKINZK International Group Co Ltd
$ 0.5503
(-11.14%)
113.04k
ELABElevai Labs Inc
$ 0.0244
(0.00%)
7.36M
DBGIDigital Brands Group Inc
$ 0.1471
(-18.48%)
5.96M
WKSPWorksport Ltd
$ 1.1899
(36.77%)
4.82M
MVSTMicrovast Holdings Inc
$ 0.8531
(5.45%)
4.26M
CSCOCisco Systems Inc
$ 59.18
(-0.02%)
3M

Discussion

View Full Feed
nadodude nadodude 5 minutes ago
True, some rumors of Trump's pick came out on X, but to verify you have to go to Truth Social.  
DJT
bluesky70 bluesky70 6 minutes ago
pre r/s price is .0409
VERB
powerbattles powerbattles 6 minutes ago
You're absolutely right. He's a flipper, a fake long. No one who holds shares would be spewing the kind of nonsense he does. A -38.10% drop today is just stupid panic selling. For days, there's been a clear reason why OTCN hasn't been pushing the price below .002. All the shares restricted between 2
AFFU
WebSlinger WebSlinger 6 minutes ago
Quarterly financial report is posted.

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001413119/000149315224045153/form10-q.htm
KBLB
rich2 rich2 6 minutes ago
I believe after 30 years around mining stocks; NBRI in one or two more PR's will hit a grand slam home run in less than one year
NBRI
JTORENCE JTORENCE 6 minutes ago
tunnelvisionofplenty another minion heard from. BYE-BYE
NWBO
longboard251 longboard251 7 minutes ago
Are earnings after hours on Thurs 11/14?
ASTS
MightyX MightyX 7 minutes ago
Price only closed lower to allow dilution to qualify at lower prices. $26k bid doesn’t lie, they waiting like criminals to be filled otherwise .0002’s would get taken
TPTW
PurpleCritter2001 PurpleCritter2001 7 minutes ago
No insider sales to date in 2024. You have as much respect for the truth as a tomcat does a marriage license. I have waited most of the day for your links and I gave you mine. Put up or shut up.

Purplecritter2001
LWLG
The GidDy uP Kid The GidDy uP Kid 7 minutes ago
weekLy…
https://schrts.co/rQapYtWm
BWEN
ProfitChaser ProfitChaser 8 minutes ago
Sounds nice. Grabbed a starter today
The GidDy uP Kid The GidDy uP Kid 8 minutes ago
BWEN weekLy…
https://schrts.co/rQapYtWm
BWEN
shazam1355 shazam1355 8 minutes ago
Looks like we are around 43 Million shares owned by Institutions....so 35% owned by Institutions....

Institutional Shares (Long) 43,412,462 - 35.96% (ex 13D/G) - change of 1.21MM shares 3.69% MRQ

Institutional Owners 229 total, 222 long only, 4 short only, 3 long/short
LWLG
geocappy1 geocappy1 8 minutes ago
I do not know everything that the CEO or BOD knows but I can not think of one reason why it makes sense to sell at this point.
CDMO
shajandr shajandr 8 minutes ago
🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣
😂😂😂😂😂😂😂😂😂😂
NLST
The GidDy uP Kid The GidDy uP Kid 8 minutes ago
BWEN weekLy…
https://schrts.co/rQapYtWm
BWEN
dewophile dewophile 8 minutes ago
I'm not suggesting anything I posted simply because i found it a curious coincidence that the ark bio drug had a new trial listing for a QTC trial that was posted within a week of ENTA's posting their QTC trial. I honestly didn't know the current status of ziresovir, and still don't really ark is pr
ENTA
al dean al dean 8 minutes ago
OOOOOPS AH is low ! Please don't let me buy any ! -- till company decision by Nov. 16 Th
SMCI
1vman 1vman 8 minutes ago
***** Wow ! Reclassification meetings not happening anytime soon as da can keeps getting "KICKED" down the road -- Wh👀ps !
Looks like no 🚽MJNA🚽 run coming anytime s👀n -- Going to be a long rest of da year

1. SET BUY LOW shares
2. SET SELLs
MJNA
RKT989 RKT989 8 minutes ago
or yours
ERHE
RKT989 RKT989 8 minutes ago
or yours
ERHE

Your Recent History

AMEX
DUSA
Davis Select US Equity
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved